BackLemaitre Vascular Overview

Lemaitre Vascular Receivables

Track Lemaitre Vascular's receivables ($36M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$35.68M
↓ 2.34% YoYΔ $-855000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lemaitre Vascular Receivables History

Loading

Lemaitre Vascular vs. peers: Receivables Comparison

Loading

Lemaitre Vascular Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lemaitre Vascular (LMAT) FAQ

Lemaitre Vascular (LMAT) currently reports a receivables of $36M as of June 2026. That compares with $37M in the prior-year period — down 2.3% year over year. Use the charts on this page to explore Lemaitre Vascular's receivables history and peer comparisons.

Lemaitre Vascular's receivables decreased from $37M to $36M — a 2.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lemaitre Vascular reported $36M in receivables as of June 2026. That compares with $37M in the prior-year period — down 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lemaitre Vascular, and consider following LMAT for alerts when major investors trade the stock.

Lemaitre Vascular is classified in the Healthcare sector. On receivables, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LMAT with unrelated industries.